EPITOPE SUMMARY | |
---|---|
SLLMWITQV is a linear peptidic epitope (epitope ID ) studied as part of Protein OPG074 (UniProt:Q80HX1) from Vaccinia virus (vaccinia virus VV). The epitope is an analog of: SLLMWITQC from Homo sapiens (human) NY-ESO-1 protein. The epitope is an analog of: SLLMWITQC from Homo sapiens (human) Cancer/testis antigen 1. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, B cell assays, MHC ligand assays and has 3D structure(s) , , , , , , , , and . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
B Cell Assay(s) | |
Assay Type | Positive / All |
dissociation constant KD | / |
off rate | / |
on rate | / |
3D structure | / |
qualitative binding | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
IFNg release | / |
3D structure | / |
dissociation constant KD | / |
T cell- APC binding | / |
proliferation | / |
cytotoxicity | / |
off rate | / |
on rate | / |
activation | / |
IL-12 release | / |
IL-1b release | / |
IL-2 release | / |
IL-6 release | / |
protection from tumor challenge after adoptive transfer | / |
TNFa release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |